During the past decade, Allergy and Asthma Medical Group and Research Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 12 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy and Asthma Medical Group and Research Center" #1 sponsor was "Aimmune Therapeutics, Inc." with 7 trials, followed by "Sunovion" with 7 trials sponsored, "Meda Pharmaceuticals" with 6 trials sponsored, "Allergy & Asthma Medical Group & Research Center" with 2 trials sponsored and "ALK-Abelló A/S" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy and Asthma Medical Group and Research Center" #1 collaborator was "Pacira Pharmaceuticals, Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Allergy and Asthma Medical Group and Research Center" are "Asthma" (8 trials), "Peanut Allergy" (7 trials), "Perennial Allergic Rhinitis" (7 trials), "Seasonal Allergic Rhinitis" (4 trials) and "Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Allergy and Asthma Medical Group and Research Center" in a lesser frequency.

Most popular intervention types in "Allergy and Asthma Medical Group and Research Center" are "Drug" (23 trials), "Biological" (10 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "AR101" (4 trials), "0.15% azelastine hydrochloride" (2 trials), "AR101 powder provided in capsules & sachets" (2 trials) and "Ciclesonide nasal aerosol 37 mcg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Allergy and Asthma Medical Group and Research Center" are 34 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Allergy and Asthma Medical Group and Research Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in Allergy and Asthma Medical Group and Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Allergy and Asthma Medical Group and Research Center, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".